Anti-CD79a Antibody [C1-E8]
EM1902-29
ApplicationsFlow Cytometry, Western Blot
Product group Antibodies
ReactivityHuman, Rat
TargetCD79A
Overview
- SupplierHUABIO
- Product NameAnti-CD79a Antibody [C1-E8]
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Western Blot
- Applications SupplierWB,FC
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDC1-E8
- Concentration2 mg/ml
- ConjugateUnconjugated
- Gene ID973
- Target nameCD79A
- Target descriptionCD79a molecule
- Target synonymsIGA, IGAlpha, MB-1, MB1, B-cell antigen receptor complex-associated protein alpha chain, CD79a antigen (immunoglobulin-associated alpha), CD79a molecule, immunoglobulin-associated alpha, MB-1 membrane glycoprotein, ig-alpha, membrane-bound immunoglobulin-associated protein, surface IgM-associated protein
- HostMouse
- IsotypeIgG
- Protein IDP11911
- Protein NameB-cell antigen receptor complex-associated protein alpha chain
- Scientific DescriptionCluster of differentiation CD79A also known as B-cell antigen receptor complex-associated protein alpha chain and MB-1 membrane glycoprotein, is a protein that in humans is encoded by the CD79A gene. The CD79a protein together with the related CD79b protein, forms a dimer associated with membrane-bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR). This occurs in a similar manner to the association of CD3 with the T-cell receptor, and enables the cell to respond to the presence of antigens on its surface. It is associated with agammaglobulinemia-3. CD79a plays multiple and diverse roles in B cell development and function. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells. Association of the CD79a/b heterodimer with the immunoglobulin heavy chain is required for surface expression of the BCR and BCR induced calcium flux and protein tyrosine phosphorylation. Genetic deletion of the transmembrane exon of CD79A results in loss of CD79a protein and a complete block of B cell development at the pro to pre B cell transition. Similarly, humans with homozygous splice variants in CD79A predicted to result in loss of the transmembrane region and a truncated or absent protein display agammaglobulinemia and no peripheral B cells.
- ReactivityHuman, Rat
- Reactivity SupplierHuman,Rat
- Reactivity Supplier NoteMouse
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161